Gracell Biotechnologies Inc.

At this time, all participants are in a listen-only mode. After opening remarks, we will open the call for your questions. Instructions for queuing up will be given at that time. I would now like to turn the call over to Dr. Kevin Shee, CFO. Please go ahead.

Good morning and welcome to Grace Health First Quarter 2022 Corporate Update Conference Call on the webcast. With me today are Green Cell's founder and the chief executive officer, Dr. William Tao, and our chief medical officer, Dr. William Lee. We're excited to discuss the progress of our differentiated clinical pipeline of CAR-T therapies on today's call. We also look forward to sharing with you our recent business developments and upcoming objectives as we head into 2023. As our former remarks, we will conduct a question and answer session. This morning, Grayscale issued a press release announcing unaudited financial results for the quarter and full year ended December 34th, 2022. We encourage everyone to read this press release and would like to remind you that this call is being recorded for replay. Please note that for certain information discussed on the call today, including financial data, clinical data, and the future plans of our program, resale management will be making forward-looking statements. Actual results could differ materially from those stated or implied by those forward-looking statements as a result of various important factors. and please refer to the risk factors section of our latest 20-hour filing with SEC for a full disclosure of these risks and the factors. This conference call contains time-sensitive information that's accurate only as of the date of this live broadcast, March 13, 2023. RISA undertakes no obligation to revise or update any forward-looking statement to reflect events or circumstances after the date of this conference call, except as may be required by equitable securities law.

I will now turn the call over to Greece House CEO, Dr. William Chao. William. Thank you, Kevin.